Use of immunohistochemistry for SSTR2A to support a diagnosis of phosphaturic mesenchymal tumour

Pathology

Volumn 47, Issue 2, 2015, Pages 173-175

  Clugston, Ellery ^a   Gill, Anna C ^a,b   Graf, Nicole ^c   Bonar, Fiona ^d   Gill, Anthony J ^a,e,f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Pediatrics Hornbsy Ku Ring Gai Hospital   (Australia)

^c Department of Anatomical Pathology Childrens Hospital Westmead   (Australia)

^d DOUGLASS HANLY MOIR PATHOLOGY   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR 2;

CASE REPORT; CHILD; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MANDIBULAR NEOPLASMS; MESENCHYMOMA; METABOLISM; PATHOLOGY;

CHILD; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MANDIBULAR NEOPLASMS; MESENCHYMOMA; RECEPTORS, SOMATOSTATIN;

EID: 84927671563     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000221     Document Type: Article

References (7)

1. Nelson AW, Clifton-Bligh RJ, Mirams M., et al. Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia. J Clin Endocrinol Metab 2003; 88: 4088-94.
2. Folpe AL, Fanburg-Smith JC, Billings S.D., et al. Most osteomalacia-associated mesenchymal tumors area single histopathologic entity: ananalysis of32cases and a comprehensive review of the literature. Am J Surg Pathol 2004; 28:1-30.
3. Houang M, Clarkson A, Sioson L., et al. Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A). Hum Pathol 2013; 44: 711-2718.
4. Bahrami A, Weiss SW, Montgomery E, et al. RT-PCR analysis for FGF23 using paraffin sections in the diagnosis of phosphaturic mesenchymal tumors with and with out known tumor in ducedosteomalacia. Am J Surg Pathol 2009; 33:1348-54.
5. Graham R, Krishnamurthy S, Oliviera A., et al. Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas. J Clin Pathol 2012; 65: 907-9.
6. Clifton-Bligh RJ, Hofman MS, Duncan E, et al. Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT. J Clin Endocrinol Metab 2013; 98: 687-94.
7. Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed Lyon: IARC Press; 2013.